ABSTRACT
Background Osteoporosis is most common skeletal disorders that weaken bones and increase their susceptibility to fractures. It is becoming an urgent and serious global epidemic.Early diagnosis and treatment are essential to reduce morbidity and mortality associated with it. This study aimed to find out the prevalence of osteoporosis among patients attending at Manakamana Hospital, Bharatpur, Chitwan.
Methods A descriptive, cross-sectional study was adopted and 623 patients attending at orthopaedic outpatients department (OPD) of Manakamana Hospital were selected using consecutive sampling technique. Data were collected from 15th October 2021 to 15th April, 2022, by using interview schedule, chart review and BMD measurement through calcaneal ultrasonography. Ethical approval was obtained from NHRC-IRC prior to study procedures. Obtained data were analysed using descriptive statistics and association between the variables were measured using chi-square test.
Results The mean age of the patients was 43.5 (±14.26) years. Nearly half (44%, n=274) were middle aged adults, 59.7% were female and 56.0% were involved in agriculture and household chores. Nearly half of the patients (45.7%) were overweight/ obese, 7.9% were smokers and 13.5% had habit of alcohol use. Osteopenia or low bone density was detected in 58.9% patients and 19.4% had osteoporosis. The prevalence of osteoporosis was significantly associated with age group (p=<0.001) and educational status (p=0.013) of the patients.
Conclusions Osteoporosis and osteopenia are prevalent in patients attending in the hospital. Hence, awareness, early screening, treatment is necessary for the hospital attended patients to minimize the risk of fracture and the consequences associated with it.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work. NO.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Nepal Health Research Council Ref. Num. 3137 ERB Protocol Num. 263/2921P
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Conflict of Interest: None
Data Availability
Data are fully available from the primary author at any time from Dr Shankar Dhakal. Email: dhakalshankar1{at}gmail.com
